Statement from Vireo Health on Department of Health’s Decision to Improve Patient Access to Medical Marijuana for New Yorkers Prescribed Opioids
The following statement regarding New York State’s plan to allow medical cannabis to be used as an alternative to prescription opioids can be attributed to Dr. Stephen Dahmer, Chief Medical Officer of Vireo Health, one of only 10 organizations licensed in the state to grow, cultivate, manufacture and sell medical cannabis:
“Today’s announcement made by Department of Health Commissioner Dr. Howard Zucker is an important step towards potentially helping thousands of New Yorkers that rely on opioid-based medications to treat their pain. We are fully prepared to work collaboratively with the Department to improve medical cannabis access and support for more New Yorkers who can benefit from these medicines.”
About Vireo Health of New York
Vireo Health of New York is a physician-led company dedicated to providing best-in-class cannabis-based medications and compassionate care. The Company is a proven leader in the field of medical marijuana. In December 2015, Vireo’s products became the first to be certified Kosher by the Orthodox Union. In addition to brick-and-mortar dispensary locations, Vireo launched the first medical marijuana home delivery service in the New York City area, now available throughout New York City, Westchester, Rockland, Nassau and parts of Suffolk County. For more information, visit https://vireohealth.com/ny/.